Why Is Biophytis (BPTS) Stock Up 43% Today?

Biophytis (NASDAQ:BPTS) stock is rocketing higher on Tuesday after releasing its earnings results for the full year of 2023.Biophytis  is still a clinical-stage biotechnology, which means it had no revenue to report for 2023. However, its net loss for the quarter was 17.03 million euros. That’s an improvement over its net loss of 24.22 million euros in 2022.Biophytis notes there were several factors that resulted in it reporting a lower net loss. That includes reduced research and development costs due to c ...